BMEA

#3843
Biomea Fusion, Inc. - Common Stock
1.7 3 USD
+0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.73
1.73
Year Range
0.87
2.99
Daily Change
+2.98%
Monthly Change
+42.98%
6 month change
+26.28%
Year Change
-11.73%
Previous Close
1.6 8
Open
1.7 3
Low
1.7 3
High
1.7 3
Volume
27
Open full chart

Financials

Overview Statement Statistics Documents

2026

Current report, Q3 FY2026
Biomea Fusion, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Biomea Fusion, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Biomea Fusion, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Biomea Fusion, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Biomea Fusion, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Biomea Fusion, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Biomea Fusion, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Biomea Fusion, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Biomea Fusion, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Biomea Fusion, Inc. annual report, FY2025
10-K

Biomea Fusion, Inc. current report, Q2 FY2026

Full document

Biomea Fusion, Inc. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K covers the Annual Meeting of Stockholders held on June 10, 2026. Biomea Fusion, Inc. (BMEA), an emerging growth company incorporated in Delaware, reported the results of shareholder votes regarding director elections and the ratification of its independent auditor.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.

Material Changes and Voting Results

Shareholders voted on two proposals at the Annual Meeting. The total shares entitled to vote were 72,299,440, with 43,924,456 shares present or represented by proxy.

  • Proposal 1: Election of Directors
    • Rainer (Ramses) Erdtmann: Elected as a Class II director. Votes For: 10,860,715; Votes Withheld: 12,956,116.
    • Eric Aguiar: Elected as a Class II director. Votes For: 9,553,344; Votes Withheld: 14,263,487.
    • Broker Non-Votes: 20,107,625 shares were recorded as broker non-votes for this proposal.
  • Proposal 2: Ratification of Independent Auditor
    • Shareholders ratified the appointment of Deloitte & Touche LLP for the fiscal year ending December 31, 2026.
    • Votes For: 40,209,966
    • Votes Against: 3,561,734
    • Abstentions: 152,756
    • Broker Non-Votes: 0

Guidance, Outlook, and Risks

The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The report is limited to the disclosure of voting outcomes.

Key Facts for Investor Verification

  • Verify the tenure of the newly elected directors (Rainer Erdtmann and Eric Aguiar), who serve until the 2029 Annual Meeting.
  • Note the significant number of votes withheld for both director nominees, indicating potential shareholder dissatisfaction or abstention.
  • Confirm the high volume of broker non-votes (20.1 million shares) on the director election, which may impact future voting thresholds.
  • Review the substantial number of votes against the auditor ratification (3.56 million) relative to the votes in favor.

News